Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BD Combinations for eradication of Helicobacter pylori
A02BD12 Rabeprazole, amoxicillin and clarithromycin
D10519 Rabeprazole, amoxicillin and clarithromycin <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
619 Miscellaneous
6199 Miscellaneous
D10519 Rabeprazole, amoxicillin and clarithromycin
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D10519 Rabeprazole, amoxicillin and clarithromycin
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10519 Rabeprazole, amoxicillin and clarithromycin
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D10519 Rabeprazole, amoxicillin and clarithromycin
Transporter inhibitor
DG01622 ABCB1 inhibitor
D10519 Rabeprazole, amoxicillin and clarithromycin
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Combination for eradication of H. pylori
D10519 Rabeprazole, amoxicillin and clarithromycin <JP>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10519
Drug transporters
D10519